FeesSafety
Pluang+

Cancore raises $7.2M seed round to expand cross-blockchain trading and automation tools.

Protocol Fundamentals
29 Oct 2026, 04:30 WIB
AMBCrypto
View Source
Bullish
Cancore raises $7.2M seed round to expand cross-blockchain trading and automation tools.

Cancore, a trading platform on Canton, secured $7.2 million in seed funding from investors including Paper Ventures and ArkStream Capital. The company aims to connect Canton-based assets with buyers and sellers on other blockchains, easing cross-network trading challenges. It plans to use the funds to enhance blockchain connections, liquidity, security, and develop AI-driven trading agents. Cancore has processed over $53 million in trades and saw a recent price and volume uptick in its CC token, though broader price declines persist.

The Canton crypto project Cancore recently raised $7.2 million in seed funding. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Oct 29, 2026 08:21 WIB: out of 50 major cryptocurrencies, 29 rose and 20 fell today. Notable movers include EGLD at Rp62.128 with a 1-day change of +2.03% and a Pluang order activity of 69% Sell / 31% Buy, UNI at Rp131.379 (+1.84%, 65% Sell / 35% Buy), and LINK at Rp213.289 (+1.73%, 65% Sell / 35% Buy).

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
1 hour ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
1 hour ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
1 hour ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
3 hours ago
Alphabet misses Q3 revenue and EPS estimates, but Cloud segment shows strong growth.

Alphabet misses Q3 revenue and EPS estimates, but Cloud segment shows strong growth.

Alphabet reported weaker-than-expected results for Q3, missing both revenue and earnings per share estimates. Most business segments showed slowing growth except for the Cloud division, which grew 103% year-over-year and improved its profit margins. ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App